251 related articles for article (PubMed ID: 24819109)
1. Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease.
Ahmed Ali U; Martin ST; Rao AD; Kiran RP
Dis Colon Rectum; 2014 May; 57(5):663-74. PubMed ID: 24819109
[TBL] [Abstract][Full Text] [Related]
2. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
Syed A; Cross RK; Flasar MH
Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.
Bafford AC; Powers S; Ha C; Kruse D; Gorfine SR; Chessin DB; Bauer JJ
J Clin Gastroenterol; 2013 Jul; 47(6):491-5. PubMed ID: 23090048
[TBL] [Abstract][Full Text] [Related]
5. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
White EC; Melmed GY; Vasiliauskas E; Dubinsky M; Ippoliti A; McGovern D; Targan S; Fleshner P
Dis Colon Rectum; 2012 May; 55(5):563-8. PubMed ID: 22513435
[TBL] [Abstract][Full Text] [Related]
6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease.
Uchino M; Ikeuchi H; Matsuoka H; Bando T; Ichiki K; Nakajima K; Tomita N; Takesue Y
Dis Colon Rectum; 2013 Oct; 56(10):1156-65. PubMed ID: 24022533
[TBL] [Abstract][Full Text] [Related]
8. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
Shental O; Tulchinsky H; Greenberg R; Klausner JM; Avital S
Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
[TBL] [Abstract][Full Text] [Related]
10. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
El-Hussuna A; Andersen J; Bisgaard T; Jess P; Henriksen M; Oehlenschlager J; Thorlacius-Ussing O; Olaison G
Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168
[TBL] [Abstract][Full Text] [Related]
11. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
[TBL] [Abstract][Full Text] [Related]
12. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
Rosenfeld G; Qian H; Bressler B
J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?
Canedo J; Lee SH; Pinto R; Murad-Regadas S; Rosen L; Wexner SD
Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715
[TBL] [Abstract][Full Text] [Related]
14. The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review.
El-Hussuna A; Krag A; Olaison G; Bendtsen F; Gluud LL
Dis Colon Rectum; 2013 Dec; 56(12):1423-33. PubMed ID: 24201398
[TBL] [Abstract][Full Text] [Related]
15. The effect of immune therapy on surgical site infection following Crohn's Disease resection.
Serradori T; Germain A; Scherrer ML; Ayav C; Perez M; Romain B; Palot JP; Rohr S; Peyrin-Biroulet L; Bresler L
Br J Surg; 2013 Jul; 100(8):1089-93. PubMed ID: 23649458
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease.
Myrelid P; Olaison G; Sjödahl R; Nyström PO; Almer S; Andersson P
Dis Colon Rectum; 2009 Aug; 52(8):1387-94. PubMed ID: 19617749
[TBL] [Abstract][Full Text] [Related]
17. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
Riss S; Schuster I; Papay P; Mittlböck M; Stift A
Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
[TBL] [Abstract][Full Text] [Related]
18. [Postoperative morbidity after bowel resections in patients with Crohn's disease: risk, management strategies, prevention].
Iesalnieks I; Dederichs F; Kilger A; Schlitt HJ; Agha A
Z Gastroenterol; 2012 Jun; 50(6):595-600. PubMed ID: 22660995
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies.
Huang W; Tang Y; Nong L; Sun Y
J Crohns Colitis; 2015 Mar; 9(3):293-301. PubMed ID: 25572276
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
Afzali A; Park CJ; Zhu K; Hu JK; Sharma P; Sinanan MN; Lee SD
Inflamm Bowel Dis; 2016 Aug; 22(8):1887-95. PubMed ID: 27057681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
